Literature DB >> 29352225

A humanized mouse model of liver fibrosis following expansion of transplanted hepatic stellate cells.

Daniel Benten1,2,3, Johannes Kluwe4, Jan W Wirth4, Nina D Thiele4, Antonia Follenzi5, Kuldeep K Bhargava6, Christopher J Palestro6, Michael Koepke4, Reni Tjandra4, Tassilo Volz4, Marc Lutgehetmann4, Sanjeev Gupta7.   

Abstract

Hepatic stellate cells (HSCs) are major contributors to liver fibrosis, as hepatic injuries may cause their transdifferentiation into myofibroblast-like cells capable of producing excessive extracellular matrix proteins. Also, HSCs can modulate engraftment of transplanted hepatocytes and contribute to liver regeneration. Therefore, understanding the biology of human HSCs (hHSCs) is important, but effective methods have not been available to address their fate in vivo. To investigate whether HSCs could engraft and repopulate the liver, we transplanted GFP-transduced immortalized hHSCs into immunodeficient NOD/SCID mice. Biodistribution analysis with radiolabeled hHSCs showed that after intrasplenic injection, the majority of transplanted cells rapidly translocated to the liver. GFP-immunohistochemistry demonstrated that transplanted hHSCs engrafted alongside hepatic sinusoids. Prior permeabilization of the sinusoidal endothelial layer with monocrotaline enhanced engraftment of hHSCs. Transplanted hHSCs remained engrafted without relevant proliferation in the healthy liver. However, after CCl4 or bile duct ligation-induced liver damage, transplanted hHSCs expanded and contributed to extracellular matrix production, formation of bridging cell-septae and cirrhosis-like hepatic pseudolobules. CCl4-induced injury recruited hHSCs mainly to zone 3, whereas after bile duct ligation, hHSCs were mainly in zone 1 of the liver lobule. Transplanted hHSCs neither transdifferentiated into other cell types nor formed tumors in these settings. In conclusion, a humanized mouse model was generated by transplanting hHSCs, which proliferated during hepatic injury and inflammation, and contributed to liver fibrosis. The ability to repopulate the liver with transplanted hHSCs will be particularly significant for mechanistic studies of cell-cell interactions and fibrogenesis within the liver.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29352225      PMCID: PMC6526950          DOI: 10.1038/s41374-017-0010-7

Source DB:  PubMed          Journal:  Lab Invest        ISSN: 0023-6837            Impact factor:   5.662


  38 in total

Review 1.  New aspects of hepatic fibrosis.

Authors:  D A Brenner; T Waterboer; S K Choi; J N Lindquist; B Stefanovic; E Burchardt; M Yamauchi; A Gillan; R A Rippe
Journal:  J Hepatol       Date:  2000       Impact factor: 25.083

Review 2.  Cytokine receptors and signaling in hepatic stellate cells.

Authors:  M Pinzani; F Marra
Journal:  Semin Liver Dis       Date:  2001-08       Impact factor: 6.115

Review 3.  Mechanisms of cell engraftment during liver repopulation with hepatocyte transplantation.

Authors:  S Gupta; K K Bhargava; P M Novikoff
Journal:  Semin Liver Dis       Date:  1999       Impact factor: 6.115

Review 4.  Emerging insights into liver-directed cell therapy for genetic and acquired disorders.

Authors:  Sanjeev Gupta; Mari Inada; Brigid Joseph; Vinay Kumaran; Daniel Benten
Journal:  Transpl Immunol       Date:  2004-04       Impact factor: 1.708

5.  Hedgehog signaling regulates epithelial-mesenchymal transition during biliary fibrosis in rodents and humans.

Authors:  Alessia Omenetti; Alessandro Porrello; Youngmi Jung; Liu Yang; Yury Popov; Steve S Choi; Rafal P Witek; Gianfranco Alpini; Juliet Venter; Hendrika M Vandongen; Wing-Kin Syn; Gianluca Svegliati Baroni; Antonio Benedetti; Detlef Schuppan; Anna Mae Diehl
Journal:  J Clin Invest       Date:  2008-10       Impact factor: 14.808

6.  Expression of insulin-like growth factor I by activated hepatic stellate cells reduces fibrogenesis and enhances regeneration after liver injury.

Authors:  S Sanz; J B Pucilowska; S Liu; C M Rodríguez-Ortigosa; P K Lund; D A Brenner; C R Fuller; J G Simmons; A Pardo; M-L Martínez-Chantar; J A Fagin; J Prieto
Journal:  Gut       Date:  2005-01       Impact factor: 23.059

7.  Hepatocyte transplantation activates hepatic stellate cells with beneficial modulation of cell engraftment in the rat.

Authors:  Daniel Benten; Vinay Kumaran; Brigid Joseph; Jörn Schattenberg; Yury Popov; Detlef Schuppan; Sanjeev Gupta
Journal:  Hepatology       Date:  2005-11       Impact factor: 17.425

8.  Inhibition of apoptosis of activated hepatic stellate cells by tissue inhibitor of metalloproteinase-1 is mediated via effects on matrix metalloproteinase inhibition: implications for reversibility of liver fibrosis.

Authors:  Frank R Murphy; Razao Issa; Xiaoying Zhou; Shabna Ratnarajah; Hideaki Nagase; Michael J P Arthur; Christopher Benyon; John P Iredale
Journal:  J Biol Chem       Date:  2002-01-16       Impact factor: 5.157

9.  Transplanted endothelial cells repopulate the liver endothelium and correct the phenotype of hemophilia A mice.

Authors:  Antonia Follenzi; Daniel Benten; Phyllis Novikoff; Louisa Faulkner; Sanj Raut; Sanjeev Gupta
Journal:  J Clin Invest       Date:  2008-03       Impact factor: 14.808

10.  Inductive angiocrine signals from sinusoidal endothelium are required for liver regeneration.

Authors:  Bi-Sen Ding; Daniel J Nolan; Jason M Butler; Daylon James; Alexander O Babazadeh; Zev Rosenwaks; Vivek Mittal; Hideki Kobayashi; Koji Shido; David Lyden; Thomas N Sato; Sina Y Rabbany; Shahin Rafii
Journal:  Nature       Date:  2010-11-11       Impact factor: 49.962

View more
  6 in total

1.  Decellularized bovine placentome for portacavally-interposed heterotopic liver transplantation in rats.

Authors:  Zurab Kakabadze; Lia Karalashvili; David Chakhunashvili; Necat Havlioglu; Merab Janelidze; Ann Kakabadze; Yogeshwar Sharma; Sanjeev Gupta
Journal:  Mater Sci Eng C Mater Biol Appl       Date:  2018-12-10       Impact factor: 7.328

2.  In Atp7b-/- Mice Modeling Wilson's Disease Liver Repopulation With Bone Marrow-Derived Myofibroblasts or Inflammatory Cells and Not Hepatocytes Is Deleterious.

Authors:  Yogeshwar Sharma; Jinghua Liu; Kathleen E Kristian; Antonia Follenzi; Sanjeev Gupta
Journal:  Gene Expr       Date:  2018-07-20

3.  Efficient Reconstitution of Hepatic Microvasculature by Endothelin Receptor Antagonism in Liver Sinusoidal Endothelial Cells.

Authors:  Neelam Yadav; Fadi Luc Jaber; Yogeshwar Sharma; Priya Gupta; Preeti Viswanathan; Sanjeev Gupta
Journal:  Hum Gene Ther       Date:  2018-12-18       Impact factor: 5.695

4.  c-Met Signaling Protects from Nonalcoholic Steatohepatitis- (NASH-) Induced Fibrosis in Different Liver Cell Types.

Authors:  Hannah K Drescher; Fabienne Schumacher; Teresa Schenker; Maike Baues; Twan Lammers; Thomas Hieronymus; Christian Trautwein; Konrad L Streetz; Daniela C Kroy
Journal:  Oxid Med Cell Longev       Date:  2018-11-12       Impact factor: 6.543

5.  BIR repeat-containing ubiquitin conjugating enzyme (BRUCE) regulation of β-catenin signaling in the progression of drug-induced hepatic fibrosis and carcinogenesis.

Authors:  Chrystelle L Vilfranc; Li-Xiao Che; Krushna C Patra; Liang Niu; Olugbenga Olowokure; Jiang Wang; Shimul A Shah; Chun-Ying Du
Journal:  World J Hepatol       Date:  2021-03-27

6.  Computational simulation of liver fibrosis dynamics.

Authors:  Misa Yoshizawa; Masahiro Sugimoto; Minoru Tanaka; Yusuyuki Sakai; Masaki Nishikawa
Journal:  Sci Rep       Date:  2022-08-18       Impact factor: 4.996

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.